MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Aon plc 8.3

RNS

RNS Number : 8099D
J.P. Morgan Securities LLC
30 October 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

AON plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.01 ordinary shares

Date of dealing

29 October 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 6,560,383  2.83

 2,635,717  1.15

(2) Derivatives (other than options)

 2,489,808  1.09

 83,903  0.04

(3)Optionsandagreementstopurchase/sell

 93,200  0.04

 

Total

 9,143,391  3.96

 2,719,620  1.19

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (USD)

 

  (Note 5)

Purchase (New Borrow)

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

25,400

 

9,843

2

190

684

9

91

65

105

83

92

54

32

35

2,100

40

1

2

200

1

37

37

15

 

6,197

684

5

3

12

15

900

35

2,100

1,200

40

12

677

1

100

180

37

15

34

NA

 

186.8000

187.6200

188.1218

189.5289

189.5550

189.8398

189.9266

190.0561

190.0960

190.1928

190.2257

190.4400

190.4926

190.5896

190.7600

190.7900

190.8900

192.6550

192.8000

194.4400

194.4403

194.7000

 

186.8000

189.5289

189.7680

189.8600

190.3300

190.3527

190.3878

190.4926

190.5896

190.7498

190.7600

191.1483

191.3885

192.6200

192.6550

193.0089

194.4403

194.7000

194.7300

       

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Long

 

 

 

 

Short

3

35

1,000

1,100

 

6,000

684

100

37

186.8000

190.4926

190.5770

190.6011

 

186.8000

189.5289

192.6550

194.4403

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

 

  None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    Yes

 

Dateofdisclosure

30 October 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

23

 

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Purchased

93,200

230.00 USD

American

15-Jan-21

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full 

         details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEWPGQAUUPUGWU